Neurolysis for the Treatment of Medial Chronic Knee Pain Due to Osteoarthritis
NCT: NCT07178951 · RECRUITING
Brief Summary
This study involves the use of sound waves to block pain signals caused by osteoarthritis of the knee. The sound waves are tightly focused on a specific area of the nerve. The sound waves cause a break in the nerve which carries pain signals. Sound waves transmit through the skin so there is no need for needles. The procedure takes approximately one hour. The device has been approved in Health Canada and Europe for the treatment of lower back pain. This study is to evaluate the use of the same device for people in Canada who have knee pain related to osteoarthritis.
Frequently Asked Questions
What is Neurolysis for the Treatment of Medial Chronic Knee Pain Due to Osteoarthritis?
Neurolysis for the Treatment of Medial Chronic Knee Pain Due to Osteoarthritis is a clinical trial registered under NCT07178951. Current status: RECRUITING.
What is the status of NCT07178951?
The current status of NCT07178951 (Neurolysis for the Treatment of Medial Chronic Knee Pain Due to Osteoarthritis) is: RECRUITING.
When did Neurolysis for the Treatment of Medial Chronic Knee Pain Due to Osteoarthritis start?
Neurolysis for the Treatment of Medial Chronic Knee Pain Due to Osteoarthritis started on 2026-09-09.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.